Gestational Trophoblastic Disease-GTD

Gestational trophoblastic disease (GTD) is a group of rare tumors originating from the cells that form the placenta.

It includes molar pregnancies and choriocarcinoma.

Most forms are highly treatable with prompt diagnosis and chemotherapy.

Overview And Clinical Background

GTD arises when placental cells grow abnormally.

It may develop after normal or molar pregnancies and can be benign or malignant.

Types:Includes hydatidiform mole, invasive mole, and choriocarcinoma.

Most cases are benign and resolve with evacuation.

Malignant variant:Choriocarcinoma requires chemotherapy.

Symptoms often resemble early pregnancy but worsen with time.

Abnormal bleeding is the most common sign.

Common symptom:Irregular or heavy vaginal bleeding post-pregnancy.

Excessive nausea or vomiting.

Red flag:Persistent elevated hCG levels after pregnancy termination.

Diagnosis involves hormone testing, imaging, and histopathologic confirmation.

Imaging:Ultrasound shows a characteristic ‘snowstorm’ pattern in molar pregnancy.

Lab tests:Elevated beta-hCG confirms ongoing trophoblastic activity.

Histology differentiates between complete and partial moles.

Treatment depends on the type and stage.

Most cases respond to uterine evacuation or chemotherapy.

Conservative:Uterine evacuation with suction curettage for non-invasive forms.

Minimally invasive options:Chemotherapy for malignant or persistent GTD.

Hysterectomy in refractory or high-risk disease.

Nearly all cases are curable with timely management.

Fertility can often be preserved post-treatment.

CureU Healthcare provides precise diagnostic support, hormonal monitoring, and expert gynecologic oncologists to ensure safe and successful recovery.

Gestational trophoblastic disease is highly treatable when monitored carefully.

Early medical attention ensures full recovery and preserved fertility.